• 1
    McGinnis JM, Foerge WH. Actual causes of death in the United States. JAMA. 1993; 270: 22072212.
  • 2
    American Cancer Society. Cancer facts and figures — 2002. New York: American Cancer Society, 2002.
  • 3
    Centers for Disease Control and Prevention. Cigarette smoking among adults — United States 1999. MMWR Morb Mortal Wkly Rep. 2001; 50: 869873.
  • 4
    Centers for Disease Control and Prevention. Tobacco use among middle and high school students — United States, 1999. MMWR Morb Mortal Wkly Rep. 2000; 49: 4953.
  • 5
    Hayashi K, Fukushima K, Sagara Y, Takeshita M. Surgical treatment for patients with lung cancer complicated by severe pulmonary emphysema. J Thorac Cardiovasc Surg. 1999; 47: 583587.
  • 6
    Johnson BE, Ihde DC, Matthews MJ, et al. Non-small cell lung cancer: major cause of late mortality in patients with small cell lung cancer. Am J Med. 1986; 80: 11031110.
  • 7
    Johnston-Early A, Cohen MH, Minna JD, et al. Smoking abstinence and small cell lung cancer survival: an association. JAMA. 1980; 244: 21752179.
  • 8
    Kawahara M, Ushijima S, Kamimori T, et al. Second primary tumors in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer. 1998; 78: 409412.
  • 9
    McCulloch TM, Jensen NF, Girod DA, Tsue TT, Weymuller EA Jr. Risk factors for pulmonary complications in the postoperative head and neck surgery patient. Head Neck. 1997; 19: 372377.
  • 10
    Okubo K, Mark EJ, Flieder D, et al. Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg. 1999; 118: 702709.
  • 11
    Richardson GE, Tucker MA, Venzon DJ, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993; 119: 383390.
  • 12
    Silverman S, Greenspan D, Gorsky M. Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancers. J Am Dent Assoc. 1993; 106: 3335.
  • 13
    Stevens MH, Gardner JW, Parkin JL, Johnson LP. Head and neck cancer survival and lifestyle change. Arch Otolaryngol. 1983; 109: 746749.
  • 14
    Van der Voet JC, Keus RB, Hart AA, Hilgers FJ, Bartelink H. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 1998; 42: 247255.
  • 15
    Gritz ER. Smoking and smoking cessation in cancer patients. Br J Addict. 1991; 86: 549554.
  • 16
    Gritz ER, Vidrine DJ, Lazev AB. Smoking cessation in cancer patients: never too late to quit. In: GivenB, GivenCW, ChampionV, KozachikS, DevossD, editors. Evidenced based interventions in oncology. New York: Springer. In press.
  • 17
    U.S. Department of Health and Human Services. The health benefits of smoking cessation: a report of the surgeon general. DHHS Pub. No. CDC 90-8416. Bethesda: U.S. Department of Health and Human Services, Centers for Disease Control, Centers for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990.
  • 18
    Stewart AL, King AC, Killen JD, Ritter PL. Does smoking cessation improve health-related quality-of-life. Ann Behav Med. 1995; 17: 331338.
  • 19
    Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993; 328: 159163.
  • 20
    Knudsen N, Schulman S, Fowler R, van den Hoek J. Why bother with stop-smoking education for lung cancer patients? Oncol Nurs Forum. 1984; 11: 3033.
  • 21
    Cox LS, Sloan JA, Patten CA, et al. Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer. Psychooncology. 2002; 11: 17.
  • 22
    Moadel AB, Lederberg MS, Ostroff JS. Nicotine dependence and withdrawal in an oncology setting: a risk factor for psychiatric comorbidity and treatment non-adherence. Psychooncology. 1999; 8: 264267.
  • 23
    Gritz ER, Schacherer C, Koehly L, Nielsen IR, Abemayor E. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck. 1999; 21: 420427.
  • 24
    Davidson AG, Duffy M. Smoking habits of long-term survivors of surgery for lung cancer. Thorax. 1982; 37: 331333.
  • 25
    Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control. 1991; 2: 105112.
  • 26
    Vander Ark W, DiNardo LJ, Oliver DS. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope. 1997; 107: 888892.
  • 27
    Knudsen N, Schulman S, van den Hoek J, Fowler R. Insights on how to stop smoking: a survey of patients with lung cancer. Cancer Nurs. 1985; 8: 145150.
  • 28
    Dresler CM, Bailey M, Roper CR, Patterson GA, Cooper JD. Smoking cessation and lung cancer resection. Chest. 1996; 110: 11991202.
  • 29
    Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995; 75: 569576.
  • 30
    Schnoll RA, Malstrom M, James C, et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Ed Counseling. 2002; 46: 137145.
  • 31
    Wewers ME, Jenkins L, Mignery T. A nurse-managed smoking cessation intervention during diagnostic testing for lung cancer. Oncol Nurs Forum. 1997; 24: 14191422.
  • 32
    Sarna L. Smoking behaviors of women after diagnosis with lung cancer. J Nurs Scholarship. 1995; 27: 3541.
  • 33
    Cox LS, Patten CA, Ebbert JO, et al. Tobacco use outcomes among lung cancer patients treated for nicotine dependence. J Clin Oncol. 2002; 20: 34613469.
  • 34
    Browning KK, Ahijevych KL, Ross P, Wewers ME. Implementing the Agency for Health Care Policy and Research's smoking cessation guideline in a lung cancer surgery clinic. Oncol Nurs Forum. 2000; 27: 12481254.
  • 35
    Smith PM, Reilly KR, Miller NH, DeBusk RF, Taylor CB. Application of a nurse-managed inpatient smoking cessation program. Nicotine Tob Res. 2002; 4: 211222.
  • 36
    Wewers ME, Bowen JM, Stanislaw AE, Desimone VB. A nurse-delivered smoking cessation intervention among hospitalized postoperative patients — influence of a smoking-related diagnosis: a pilot study. Heart Lung. 1994; 23: 151156.
  • 37
    Stanislaw AE, Wewers ME. A smoking cessation intervention with hospitalized surgical cancer patients: a pilot study. Cancer Nurs. 1994; 17: 8186.
  • 38
    Griebel B, Wewers ME, Baker CA. The effectiveness of a nurse-managed minimal smoking cessation intervention among hospitalized patients with cancer. Oncol Nurs Forum. 1998; 25: 897902.
  • 39
    Gritz ER, Carr CR, Rapkin D, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993; 2: 261270.
  • 40
    Prochaska JO, DiClemente CC. The transtheoretical approach: towards a systematic eclectic framework. In: NorcrossJC, editor. Handbook of eclectic psychotherapy. New York: Brunner-Mazel, 1986: 163200.
  • 41
    DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991; 59: 295304.
  • 42
    Prokhorov AV, Hudmon KS, Gritz ER. Promoting smoking cessation among cancer patients: a biobehavioral model. Oncology. 1997; 11: 18071813.
  • 43
    McBride CM, Scholes D, Grothaus LC, Curry SJ, Ludman E, Albright J. Evaluation of a minimal self-help smoking cessation intervention following cervical cancer screening. Prev Med. 1999; 29: 133138.
  • 44
    Cox LS, Jett JR, Patten CA, et al. Smoking behavior change following spiral chest CT screening. Paper presented at the ninety-eighth International Conference of the American Thoracic Society, Atlanta, Georgia, May 17–22 2002.
  • 45
    Hay JL, Ostroff JS, Crus GD, LeGeros RZ, Kenigsberg H, Franklin DM. Oral cancer risk perception among participants in an oral cancer screening program. Cancer Epidemiol Biomarkers Prev. 2002; 11: 155158.
  • 46
    Ostroff JS, Buckshee N, Mancuso CA, Yankelevitz DF, Henschke CI. Smoking cessation following CT screening for early detection of lung cancer. Prev Med. 2001; 33: 613621.
  • 47
    Rice VH, Stead LF. Nursing interventions for smoking cessation. Cochrane Database Syst Rev. 2001; CD001183.
  • 48
    Mollner A, Villebro N, Pederson T. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2001; CD002294.
  • 49
    Bluman LG, Mosca L, Newman N, Simon DG. Preoperative smoking habits and postoperative pulmonary complications. Chest. 1998; 113: 883889.
  • 50
    Schwilk B, Bothner U, Schraag S, Gerogieff M. Perioperative respiratory events in smokers and non-smokers undergoing general anesthesia. Acta Anestesiol Scand. 1997; 41: 348355.
  • 51
    Akrawi W, Benumof JL. A pathophysiological basis for informed preoperative smoking cessation counseling. J Cardiothorac Vasc Anesth. 1997; 11: 629664.
  • 52
    Silverstein P. Smoking and wound healing. Am J Med. 1992; 93 (Suppl 1A): 22S24S.
  • 53
    Rigotti NA, Munafo MR, Murphy MF, Stead LF. Interventions for smoking cessation in hospitalized patients. Cochrane Database Syst Rev. 2001; CD001837.
  • 54
    Silagy C, Stead LF. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2001; CD000165.
  • 55
    Haupt R, Byrne J, Connelly RR, et al. Smoking habits in survivors of childhood and adolescent cancer. Med Pediatr Oncol. 1992; 20: 301306.
  • 56
    Tao ML, Guo MD, Weiss R, et al. Smoking in adult survivors of childhood acute lymphoblastic leukemia. J Natl Cancer Inst. 1998; 90: 219225.
  • 57
    Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer. 2000; 88: 674684.
  • 58
    Corkery JC, Li FP, McDonald JA, Hanley JA, Holmes GE, Holmes FF. Kids who really shouldn't smoke. N Engl J Med. 1979; 300: 1279.
  • 59
    Tyc VL, Hadley W, Crockett G. Predictors of intentions to use tobacco among adolescent survivors of cancer. J Pediatr Psychol. 2001; 26: 117121.
  • 60
    Hollen PJ, Hobbie WL, Finley SM, Hiebert SM. The relationship of resiliency to decision making and risk behaviors of cancer-surviving adolescents. J Pediatr Oncol Nurs. 2001; 18: 188204.
  • 61
    Bolinger C. Smoking prevention in childhood cancer survivors. J Pediatr Oncol Nurs. 1994; 11: 167171.
  • 62
    Gritz ER, Kristeller JL, Burns DM. Treating nicotine addiction in high-risk groups and patients with medical co-morbidity. In OrleansCT, SladeJ, editors. Nicotine addiction: principles and management. New York: Oxford University Press, 1993: 279309.
  • 63
    Agency for Health Care Policy and Research. Treating tobacco use and dependence: a clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services; 2000 AHRQ Pub. No. 00-0032.
  • 64
    Hecht JP, Emmons KM, Brown RA, et al. Smoking interventions for patients with cancer: guidelines for nursing practice. Oncol Nurs Forum. 1994; 21: 16571666.
  • 65
    Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. JAMA. 1995; 274: 13531358.
  • 66
    Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999; 340: 685691.
  • 67
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association, 1994.
  • 68
    Cepeda-Benito A. Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol. 1993; 61: 822830.
  • 69
    Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA. 1994; 271: 19401947.
  • 70
    Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997; 337: 11951202.
  • 71
    Hughes JR, Higgins ST, Bickel WK. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction. 1994; 89: 14611470.
  • 72
    Gross J, Stitzer ML. Nicotine replacement: ten-week effects on tobacco withdrawal symptoms. Psychopharmacology. 1989; 98: 334341.
  • 73
    Glassman AH. Cigarette smoking: implication for psychiatric illness. Am J Psychiatry. 1993; 150: 546553.
  • 74
    Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addict Dis. 1998; 17: 3546.
  • 75
    Niaura R, Britt DM, Borelli B, Shadel WG, Abrams DB, Goldstein MG. History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob Res. 1999; 1: 251257.
  • 76
    National Institutes of Health. Health implications of smokeless tobacco use. NIH Consensus Statement. 1986; 6: 117.
  • 77
    Mattson ME, Winn DM. Smokeless tobacco: association with increase cancer risk. NCI Monogr. 1989; 8: 1316.
  • 78
    Hanson BS, Isacsson SO, Janzon L, Lindell SE. Social support and stopping smoking for good. Is there an association? Results from the population study, “Men born in 1914,” Malmo, Sweden. Addict Behav. 1990; 15: 221233.
  • 79
    Dale LC, Olsen DA, Patten CA, et al. Predictors of smoking cessation among elderly smokers treated for nicotine dependence. Tob Control. 1997; 6: 181187.
  • 80
    McDuffie HH. Clustering of cancer in families of patients with primary lung cancer. J Clin Epidemiol. 1991; 44: 6976.
  • 81
    Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst. 1986; 76: 217222.
  • 82
    Hughes JR, Keely JP, Niaura RS. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003; 5: 1325.
  • 83
    Curry SJ, McBride CM. Relapse prevention for smoking cessation: review and evaluation of concepts and interventions. Annu Rev Public Health. 1994; 15: 345366.
  • 84
    Wynd CA. Relaxation imagery used for stress reduction in the prevention of smoking relapse. J Adv Nurs. 1992; 17: 294302.
  • 85
    Ockene JK, Mermelstein RJ, Bonollo DS, et al. Relapse and maintenance issues for smoking cessation. Health Psychol. 2000; 19: 1731.
  • 86
    Hays JT, Hurt RD, Rigotti NA, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: a randomized, controlled trial. Ann Intern Med. 2001; 135: 423433.
  • 87
    Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993; 2: 169180.
  • 88
    Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Med Care. 1992; 30: 473483.
  • 89
    Gough IR, Furnival CM, Schilder L, Grove W. Assessment of the quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol. 1983; 19: 11611165.
  • 90
    Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer. 1993; 29A(Suppl 1): S51S58.